These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30534029)

  • 21. Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis.
    Gu DH; Kim MY; Seo YS; Kim SG; Lee HA; Kim TH; Jung YK; Kandemir A; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH
    Clin Mol Hepatol; 2018 Sep; 24(3):319-330. PubMed ID: 29706058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed Tomography-Determined Body Composition Abnormalities Usefully Predict Long-term Mortality in Patients With Liver Cirrhosis.
    Cho YS; Lee HY; Jeong JY; Lee JG; Kim TY; Nam SW; Sohn JH
    J Comput Assist Tomogr; 2021 Sep-Oct 01; 45(5):684-690. PubMed ID: 34407059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients.
    Kim TY; Suk KT; Jeong SW; Ryu T; Kim DJ; Baik SK; Sohn JH; Jeong WK; Choi E; Jang JY; Kim MY
    J Korean Med Sci; 2019 Aug; 34(33):e223. PubMed ID: 31436052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
    Praktiknjo M; Book M; Luetkens J; Pohlmann A; Meyer C; Thomas D; Jansen C; Feist A; Chang J; Grimm J; Lehmann J; Strassburg CP; Abraldes JG; Kukuk G; Trebicka J
    Hepatology; 2018 Mar; 67(3):1014-1026. PubMed ID: 29059469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation.
    Tsien C; Garber A; Narayanan A; Shah SN; Barnes D; Eghtesad B; Fung J; McCullough AJ; Dasarathy S
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1250-7. PubMed ID: 24443785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis.
    Moctezuma-Velazquez C; Ebadi M; Bhanji RA; Stirnimann G; Tandon P; Montano-Loza AJ
    Clin Nutr; 2019 Dec; 38(6):2696-2703. PubMed ID: 30545661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.
    Ebadi M; Montano-Loza AJ
    Dig Liver Dis; 2019 Nov; 51(11):1493-1499. PubMed ID: 31221549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.
    Kim HY; Jang JW
    World J Gastroenterol; 2015 Jul; 21(25):7637-47. PubMed ID: 26167066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China.
    Zeng X; Shi ZW; Yu JJ; Wang LF; Sun CY; Luo YY; Shi PM; Lin Y; Chen YX; Guo J; Zhang CQ; Xie WF
    Hepatol Int; 2024 Apr; 18(2):673-687. PubMed ID: 37332023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myostatin in combination with creatine phosphokinase or albumin may differentiate patients with cirrhosis and sarcopenia.
    Alexopoulos T; Vasilieva L; Kontogianni MD; Tenta R; Georgiou A; Stroumpouli E; Mani I; Alexopoulou A
    Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G543-G551. PubMed ID: 34469188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis.
    Eriksen CS; Kimer N; Suetta C; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G729-G740. PubMed ID: 33729006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive impact of obesity on the prognosis of liver cirrhosis.
    Endo K; Kakisaka K; Abe T; Yusa K; Nakaya I; Watanabe T; Suzuki A; Yoshida Y; Oikawa T; Miyasaka A; Kuroda H; Matsumoto T
    J Gastroenterol Hepatol; 2024 Aug; 39(8):1663-1672. PubMed ID: 38700075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
    J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid Muscle Loss Negatively Impacts Survival in Critically Ill Patients With Cirrhosis.
    Ju S; Choi SM; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Lee J
    J Intensive Care Med; 2020 Jul; 35(7):663-671. PubMed ID: 29742956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications.
    Majeed T; Sharma B; Sharma R; Bodh V; Chauhan A; Surya M; Mir BA; Sharma N; Sharma D
    Indian J Gastroenterol; 2024 Aug; 43(4):813-820. PubMed ID: 38849681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.
    Tandon P; Ney M; Irwin I; Ma MM; Gramlich L; Bain VG; Esfandiari N; Baracos V; Montano-Loza AJ; Myers RP
    Liver Transpl; 2012 Oct; 18(10):1209-16. PubMed ID: 22740290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.
    Giusto M; Lattanzi B; Albanese C; Galtieri A; Farcomeni A; Giannelli V; Lucidi C; Di Martino M; Catalano C; Merli M
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):328-34. PubMed ID: 25569567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation.
    Golse N; Bucur PO; Ciacio O; Pittau G; Sa Cunha A; Adam R; Castaing D; Antonini T; Coilly A; Samuel D; Cherqui D; Vibert E
    Liver Transpl; 2017 Feb; 23(2):143-154. PubMed ID: 28061014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis.
    Kitajima Y; Takahashi H; Akiyama T; Murayama K; Iwane S; Kuwashiro T; Tanaka K; Kawazoe S; Ono N; Eguchi T; Anzai K; Eguchi Y
    J Gastroenterol; 2018 Mar; 53(3):427-437. PubMed ID: 28741271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
    Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.